UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 52

Sortiert nach

Quantitative determination of trace level (ng g) contents of rhodium and palladium in copper-rich minerals using LA-ICP-MS

Journal of analytical atomic spectrometry, 2020-03, Vol.35 (3), p.534-547

2020

Volltextzugriff (PDF)

Elimination of the memory effects of gold, mercury and silver in inductively coupled plasma atomic emission spectroscopy

Journal of analytical atomic spectrometry, 2000, Vol.15 (4), p.409-413

2000

Volltextzugriff (PDF)

INTENSIVE FOREST MANAGEMENT AND THE USE OF PESTICIDES: A CASE STUDY OF PESTICIDE USE AND ALTERNATIVES IN MAINE

PAINTER, PAMELA WEE

1981

Volltextzugriff (PDF)

IL6R-STAT3-ADAR1 (P150) interplay promotes oncogenicity in multiple myeloma with 1q21 amplification

Haematologica (Roma), 2020-05, Vol.105 (5), p.1391

2020

Volltextzugriff (PDF)

2017 HRS expert consensus statement on magnetic resonance imaging and radiation exposure in patients with cardiovascular implantable electronic devices

Heart rhythm, 2017-07, Vol.14 (7), p.e97-e153

2017

Volltextzugriff (PDF)

COPA Syndrome (Ala239Pro) Presenting with Isolated Follicular Bronchiolitis in Early Childhood: Case Report

Journal of clinical immunology, 2021-10, Vol.41 (7), p.1660-1663

2021

Volltextzugriff (PDF)

Children and the Politics of Culture

Stephens, Sharon

1, 2021

Volltextzugriff (PDF)

PTEN mRNA detection by chromogenic, RNA in situ technologies: a reliable alternative to PTEN immunohistochemistry

Human pathology, 2016-01, Vol.47 (1), p.95-103

2016

Volltextzugriff (PDF)

Moisturisers from birth in at‐risk infants of atopic dermatitis – a pragmatic randomised controlled trial

Australasian journal of dermatology, 2021-11, Vol.62 (4), p.e539-e545

2021

Volltextzugriff (PDF)

Experiences and Needs of Families Caring for Children and Adolescents With Chronic Kidney Disease: A meta-Synthesis

Journal of pediatric nursing, 2022-03, Vol.63, p.52-63

2022

Volltextzugriff (PDF)

New DSM-V Neurocognitive Disorders Criteria and Their Impact on Diagnostic Classifications of Mild Cognitive Impairment and Dementia in a Memory Clinic Setting

The American journal of geriatric psychiatry, 2015-08, Vol.23 (8), p.768-779

2015

Volltextzugriff (PDF)

Tetraspanin CD53 Promotes Lymphocyte Recirculation by Stabilizing L-Selectin Surface Expression

iScience, 2020-05, Vol.23 (5), p.101104-101104, Article 101104

2020

Volltextzugriff (PDF)

Safety, Feasibility and Healthcare Cost Differences between Inpatient and Outpatient Mobilization Chemotherapy for Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma: A Single Center Experience

Blood, 2021-11, Vol.138 (Supplement 1), p.1921-1921

2021

Volltextzugriff (PDF)

Abstract A087: Enzalutamide-induced hypoxia attenuates response and promotes resistance to enzalutamide in preclinical models of prostate cancer

Cancer research (Chicago, Ill.), 2018-08, Vol.78 (16_Supplement), p.A087-A087

2018

Volltextzugriff (PDF)

Cytoplasmic FLIP(S) and nuclear FLIP(L) mediate resistance of castrate-resistant prostate cancer to apoptosis induced by IAP antagonists

Cell death & disease, 2018-10, Vol.9 (11), p.1081-13, Article 1081

2018

Volltextzugriff (PDF)

Malignant glioma subset from Actuate 1801: A phase 1/2 study of 9-ING-41, a glycogen synthase kinase 3 beta (GSK-3β) inhibitor, as a single agent and combined with chemotherapy, in patients with refractory hematologic malignancies or solid tumors

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.2051-2051

2021

Volltextzugriff (PDF)

Attenuating Adaptive VEGF-A and IL8 Signaling Restores Durable Tumor Control in AR Antagonist-Treated Prostate Cancers

Molecular cancer research, 2022-06, Vol.20 (6), p.841-853

2022

Volltextzugriff (PDF)

Population Genetic Structure of the Bean Leaf Beetle Ootheca mutabilis (Coleoptera: Chrysomelidae) in Uganda

Insects (Basel, Switzerland), 2022-06, Vol.13 (6), p.543

2022

Volltextzugriff (PDF)

CTNI-13. MALIGNANT GLIOMA SUBSET FROM ACTUATE 1801 PHASE 1/2 STUDY OF 9-ING-41, A GLYCOGEN SYNTHASE KINASE 3 BETA (GSK-3β) INHIBITOR, AS A SINGLE AGENT AND COMBINED WITH CHEMOTHERAPY REFRACTORY

Neuro-oncology (Charlottesville, Va.), 2021-11, Vol.23 (Supplement_6), p.vi61-vi62

2021

Volltextzugriff (PDF)

Abstract 1555: A gene signature associated with PTEN activation defines good outcomes in intermediate-risk prostate cancer cases

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.1555-1555

2018

Volltextzugriff (PDF)

An Observational Study of Dyspnea in Emergency Departments: The Asia, Australia, and New Zealand Dyspnea in Emergency Departments Study (AANZDEM)

Academic emergency medicine, 2017-03, Vol.24 (3), p.328-336

2017

Volltextzugriff (PDF)

Phase I study of 9-ing-41, a small molecule selective glycogen synthase kinase-3 beta (GSK-3β) inhibitor, as a single agent and combined with chemotherapy, in patients with refractory tumors

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.3507-3507

2020

Volltextzugriff (PDF)

Effects of enzastaurin and its metabolites on the QT interval in cancer patients

Journal of clinical pharmacology, 2016-01, Vol.56 (1), p.101-108

2016

Volltextzugriff (PDF)

1 – 25 von 52

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(45)
Mit Volltextzugriff
(46)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(52)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Quantitative determination of trace level (ng g) contents of rhodium and palladium in copper-rich minerals using LA-ICP-MS

Elimination of the memory effects of gold, mercury and silver in inductively coupled plasma atomic emission spectroscopy

INTENSIVE FOREST MANAGEMENT AND THE USE OF PESTICIDES: A CASE STUDY OF PESTICIDE USE AND ALTERNATIVES IN MAINE

IL6R-STAT3-ADAR1 (P150) interplay promotes oncogenicity in multiple myeloma with 1q21 amplification

2017 HRS expert consensus statement on magnetic resonance imaging and radiation exposure in patients with cardiovascular implantable electronic devices

EHRA consensus on prevention and management of interference due to medical procedures in patients with cardiac implantable electronic devices

COPA Syndrome (Ala239Pro) Presenting with Isolated Follicular Bronchiolitis in Early Childhood: Case Report

Children and the Politics of Culture

PTEN mRNA detection by chromogenic, RNA in situ technologies: a reliable alternative to PTEN immunohistochemistry

Moisturisers from birth in at‐risk infants of atopic dermatitis – a pragmatic randomised controlled trial

Experiences and Needs of Families Caring for Children and Adolescents With Chronic Kidney Disease: A meta-Synthesis

New DSM-V Neurocognitive Disorders Criteria and Their Impact on Diagnostic Classifications of Mild Cognitive Impairment and Dementia in a Memory Clinic Setting

Tetraspanin CD53 Promotes Lymphocyte Recirculation by Stabilizing L-Selectin Surface Expression

Safety, Feasibility and Healthcare Cost Differences between Inpatient and Outpatient Mobilization Chemotherapy for Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma: A Single Center Experience

Abstract A087: Enzalutamide-induced hypoxia attenuates response and promotes resistance to enzalutamide in preclinical models of prostate cancer

Cytoplasmic FLIP(S) and nuclear FLIP(L) mediate resistance of castrate-resistant prostate cancer to apoptosis induced by IAP antagonists

Malignant glioma subset from Actuate 1801: A phase 1/2 study of 9-ING-41, a glycogen synthase kinase 3 beta (GSK-3β) inhibitor, as a single agent and combined with chemotherapy, in patients with refractory hematologic malignancies or solid tumors

Attenuating Adaptive VEGF-A and IL8 Signaling Restores Durable Tumor Control in AR Antagonist-Treated Prostate Cancers

Population Genetic Structure of the Bean Leaf Beetle Ootheca mutabilis (Coleoptera: Chrysomelidae) in Uganda

Phase I Study of Elraglusib (9-ING-41), a Glycogen Synthase Kinase-3β Inhibitor, as Monotherapy or Combined with Chemotherapy in Patients with Advanced Malignancies

CTNI-13. MALIGNANT GLIOMA SUBSET FROM ACTUATE 1801 PHASE 1/2 STUDY OF 9-ING-41, A GLYCOGEN SYNTHASE KINASE 3 BETA (GSK-3β) INHIBITOR, AS A SINGLE AGENT AND COMBINED WITH CHEMOTHERAPY REFRACTORY

Abstract 1555: A gene signature associated with PTEN activation defines good outcomes in intermediate-risk prostate cancer cases

An Observational Study of Dyspnea in Emergency Departments: The Asia, Australia, and New Zealand Dyspnea in Emergency Departments Study (AANZDEM)

Phase I study of 9-ing-41, a small molecule selective glycogen synthase kinase-3 beta (GSK-3β) inhibitor, as a single agent and combined with chemotherapy, in patients with refractory tumors

Effects of enzastaurin and its metabolites on the QT interval in cancer patients

Suchergebnisse filtern